SCHEMBL23979224

SCHEMBL23979224

N#Cc1c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c(-n2c3ccccc3c3ccccc32)c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c(-n2c3ccccc3c3ccccc32)c1-n1c2ccccc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.40
KDM4E B2RXH2 2/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.37
STAT3 P40763 1/20 0.37
PDE9A O76083 1/20 0.36
PDE1C Q14123 1/20 0.36
PARP1 P09874 1/20 0.36
HTR3A P46098 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
CASP1 P29466 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPY5R Q15761 1/20 0.36
ADORA1 P30542 1/20 0.36
CYP11B2 P19099 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
DNM1 Q05193 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21884024 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL31168869 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL31175698 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL21840840 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL23263992 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL21884031 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL21765765 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL21840849 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL24328536 0.99 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1
SCHEMBL24328531 0.99 TSPO (0.40) TSPOKDM4EATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210343947-A1 BENZONITRILE DERIVATIVE AND MANUFACTURING METHOD THEREFOR, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, LIGHT-EMITTING MATERIAL, CHARGE TRANSPORT MATERIAL, LIGHT-EMITTING THIN FILM, AND ORGANIC ELECTROLUMINESCENT ELEMENT Konica Minolta, Inc. (JP) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210343947-A1 BENZONITRILE DERIVATIVE AND MANUFACTURING METHOD THEREFOR, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, LIGHT-EMITTING MATERIAL, CHARGE TRANSPORT MATERIAL, LIGHT-EMITTING THIN FILM, AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, TCF4, SLC6A11 TSPO 1127/4885KDM4E 842/4885ATM 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.